Insider Buying and Selling - TSHA

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
01/26/2026	01/27/2026	Alam Kamran CHIEF FINANCIAL OFFICER CFO	Sell	-23,849 @ $4.61	($109,943.89)	1,443,786	(-1.62%)	Direct
01/26/2026	01/27/2026	Nagendran Sukumar President and Head of R&D Officer Director	Sell	-26,918 @ $4.61	($124,091.98)	1,317,389	(-2.00%)	Direct
01/26/2026	01/27/2026	Nolan Sean P. Chief Executive Officer CEO Director	Sell	-41,312 @ $4.61	($190,448.32)	2,908,257	(-1.40%)	Direct
01/23/2026	01/27/2026	Alam Kamran CHIEF FINANCIAL OFFICER CFO	Sell	-78,968 @ $4.75	($375,098.00)	1,467,635	(-5.11%)	Direct
01/23/2026	01/27/2026	Nagendran Sukumar President and Head of R&D Officer Director	Sell	-89,132 @ $4.75	($423,377.00)	1,344,307	(-6.22%)	Direct
01/23/2026	01/27/2026	Nolan Sean P. Chief Executive Officer CEO Director	Sell	-136,789 @ $4.75	($649,747.75)	2,949,569	(-4.43%)	Direct
08/21/2025	08/22/2025	Alam Kamran CHIEF FINANCIAL OFFICER CFO	Sell	-54,491 @ $2.85	($155,299.35)	1,187,603	(-4.39%)	Direct
08/21/2025	08/22/2025	Nagendran Sukumar President and Head of R&D Officer Director	Sell	-57,054 @ $2.85	($162,603.90)	1,165,289	(-4.67%)	Direct

Taysha Gene Therapies, Inc. - TSHA